186 related articles for article (PubMed ID: 8575230)
21. Enhanced duck hepatitis B virus gene expression following aflatoxin B1 exposure.
Barraud L; Guerret S; Chevallier M; Borel C; Jamard C; Trepo C; Wild CP; Cova L
Hepatology; 1999 Apr; 29(4):1317-23. PubMed ID: 10094981
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of total saponins isolated from Taraphochlamys affinis on duck hepatitis B virus replication.
Lin X; Huang Q; Zhang S; Huang J; Huang R
Zhongguo Zhong Yao Za Zhi; 2012 Feb; 37(3):384-9. PubMed ID: 22568246
[TBL] [Abstract][Full Text] [Related]
23. Characterisation of the Indian strain of duck hepatitis B virus (DHBV) and development of a carrier duck colony for antiviral drug testing.
Munshi A; Mehrotra R; Panda SK
Trop Gastroenterol; 1994; 15(2):77-85. PubMed ID: 7831721
[TBL] [Abstract][Full Text] [Related]
24. [Antisense oligodeoxynucleotide targeted at the pre-s region of DHBV could inhibit virus replication in vivo].
He L; Wu X; Chen C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):1-4. PubMed ID: 12515159
[TBL] [Abstract][Full Text] [Related]
25. Protocatechuic aldehyde inhibits hepatitis B virus replication both in vitro and in vivo.
Zhou Z; Zhang Y; Ding XR; Chen SH; Yang J; Wang XJ; Jia GL; Chen HS; Bo XC; Wang SQ
Antiviral Res; 2007 Apr; 74(1):59-64. PubMed ID: 17298850
[TBL] [Abstract][Full Text] [Related]
26. Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds.
Civitico G; Wang YY; Luscombe C; Bishop N; Tachedjian G; Gust I; Locarnini S
J Med Virol; 1990 Jun; 31(2):90-7. PubMed ID: 1696959
[TBL] [Abstract][Full Text] [Related]
27. Selective inhibition of the reverse transcription of duck hepatitis B virus by binding of 2',3'-dideoxyguanosine 5'-triphosphate to the viral polymerase.
Howe AY; Robins MJ; Wilson JS; Tyrrell DL
Hepatology; 1996 Jan; 23(1):87-96. PubMed ID: 8550054
[TBL] [Abstract][Full Text] [Related]
28. Contribution of aflatoxin B1 and hepatitis B virus infection in the induction of liver tumors in ducks.
Cova L; Wild CP; Mehrotra R; Turusov V; Shirai T; Lambert V; Jacquet C; Tomatis L; Trépo C; Montesano R
Cancer Res; 1990 Apr; 50(7):2156-63. PubMed ID: 2107970
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of viral replication by genetically engineered mutants of the duck hepatitis B virus core protein.
von Weizsäcker F; Wieland S; Blum HE
Hepatology; 1996 Aug; 24(2):294-9. PubMed ID: 8690395
[TBL] [Abstract][Full Text] [Related]
30. Anti-HBV effect of individual traditional Chinese herbal medicine in vitro and in vivo: an analytic review.
Chen Y; Zhu J
J Viral Hepat; 2013 Jul; 20(7):445-52. PubMed ID: 23730837
[TBL] [Abstract][Full Text] [Related]
31. Cellular immune response of ducks to duck hepatitis B virus infection.
Vickery K; Cossart Y; Dixon R
J Med Virol; 1999 May; 58(1):19-25. PubMed ID: 10223541
[TBL] [Abstract][Full Text] [Related]
32. Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection.
Soni PN; Brown D; Saffie R; Savage K; Moore D; Gregoriadis G; Dusheiko GM
Hepatology; 1998 Nov; 28(5):1402-10. PubMed ID: 9794928
[TBL] [Abstract][Full Text] [Related]
33. [Experimental study on anti-duck hepatitis B viral effect of Phyllanthus urinaria of different areas and combined therapy with other drugs].
Chen YX; Guo SH; Zhang DF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Apr; 15(4):225-7. PubMed ID: 7647546
[TBL] [Abstract][Full Text] [Related]
34. Antiviral strategies in chronic hepatitis B virus infection: I. Establishment of an in vitro system using the duck hepatitis B virus model.
Bishop N; Civitico G; Wang YY; Guo KJ; Birch C; Gust I; Locarnini S
J Med Virol; 1990 Jun; 31(2):82-9. PubMed ID: 2388048
[TBL] [Abstract][Full Text] [Related]
35. Effects of Phyllanthus plant extracts on duck hepatitis B virus in vitro and in vivo.
Shead A; Vickery K; Pajkos A; Medhurst R; Freiman J; Dixon R; Cossart Y
Antiviral Res; 1992 Jun; 18(2):127-38. PubMed ID: 1416905
[TBL] [Abstract][Full Text] [Related]
36. [Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling].
Hu Q; Fang Y; Zhang ZM; Zhang XY; Zhang ZH; Yang DL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):113-5. PubMed ID: 18574531
[TBL] [Abstract][Full Text] [Related]
37. Antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L. var. grandiflorum.
Zhao G; Yin Z; Dong J
J Ethnopharmacol; 2009 Sep; 125(2):265-8. PubMed ID: 19580857
[TBL] [Abstract][Full Text] [Related]
38. [Inhibition of extracts of ampelopsis sinica roots on DHBVsAg in sera of ducklings].
Chen K; Li H; Chen Y; Zhang C
Zhong Yao Cai; 2000 Jan; 23(1):41-2. PubMed ID: 12575118
[TBL] [Abstract][Full Text] [Related]
39. Taraxacum mongolicum extract exhibits a protective effect on hepatocytes and an antiviral effect against hepatitis B virus in animal and human cells.
Jia YY; Guan RF; Wu YH; Yu XP; Lin WY; Zhang YY; Liu T; Zhao J; Shi SY; Zhao Y
Mol Med Rep; 2014 Apr; 9(4):1381-7. PubMed ID: 24481875
[TBL] [Abstract][Full Text] [Related]
40. Validation of biocides against duck hepatitis B virus as a surrogate virus for human hepatitis B virus.
Sauerbrei A; Schacke M; Glück B; Egerer R; Wutzler P
J Hosp Infect; 2006 Dec; 64(4):358-65. PubMed ID: 17011665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
